Intelligent Bio Solutions Advances FDA Submission

Intelligent Bio Solutions is making progress on its upcoming FDA 510(k) submission, having successfully completed penetration testing with no major vulnerabilities identified. The company has implemented an enhanced security architecture to ensure the integrity of test results and protect donor data. This robust security measure strengthens the foundation for their regulatory submission. The successful completion of testing indicates a high level of data security and operational readiness, positioning Intelligent Bio Solutions favorably for FDA review and potential market entry.